Sigue la actividad de operaciones con información privilegiada más reciente de MiMedx Group. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de MiMedx Group.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
May 05, 2025 | CHIEF EXECUTIVE OFFICER | 200.00K | $6.34 | $1.27M | BUY | 60.69% | 529.53K | May 02 | ||
Mar 20, 2025 | CHIEF COMMERCIAL OFFICER | -1.76K | $8.04 | -$14.14K | SELL | -0.57% | 309.08K | Mar 17 | ||
Mar 14, 2025 | GENERAL COUNSEL AND CAO | -54.60K | $7.89 | -$430.76K | SELL | -11.03% | 440.18K | Mar 13 | ||
Mar 14, 2025 | CHIEF COMMERCIAL OFFICER | -4.11K | $7.89 | -$32.40K | SELL | -1.30% | 310.84K | Mar 13 | ||
Mar 12, 2025 | GENERAL COUNSEL AND CAO | -81.45K | $7.80 | -$635.28K | SELL | -14.13% | 494.77K | Mar 10 | ||
Mar 05, 2025 | CHIEF COMMERCIAL OFFICER | 43.82K | $8.40 | -$17.74K | GRANT | 16.16% | 314.94K | Feb 28 - Mar 03 | ||
Feb 18, 2025 | CHIEF OPERATING OFFICER | -61.42K | $8.28 | -$508.56K | SELL | -13.22% | 403.02K | Feb 13 | ||
Mar 15, 2024 | GENERAL COUNSEL AND CAO | -20.38K | $7.95 | -$162.03K | SELL | -4.07% | 479.96K | Mar 13 | ||
Feb 21, 2024 | CHIEF OPERATING OFFICER | -30.76K | $8.04 | -$247.43K | SELL | -7.12% | 401.05K | Feb 16 - Feb 20 | ||
Feb 16, 2024 | CHIEF OPERATING OFFICER | -31.04K | $8.05 | -$249.76K | SELL | -6.71% | 431.81K | Feb 14 - Feb 15 | ||
Nov 22, 2023 | CHIEF FINANCIAL OFFICER | 5.00K | $7.16 | $35.79K | BUY | 5.14% | 102.20K | Nov 21 | ||
Jun 26, 2023 | CHIEF EXECUTIVE OFFICER | 100.00K | $6.40 | $640.43K | BUY | ∞ | 100.00K | Jun 22 - Jun 23 | ||
May 17, 2023 | PRESIDENT, REGENERATIVE MED. | -13.97K | $6.00 | -$83.80K | SELL | -4.21% | 317.80K | May 15 - May 16 | ||
May 12, 2023 | GENERAL COUNSEL AND CAO | -5.87K | $5.93 | -$34.79K | SELL | -1.27% | 456.56K | May 10 | ||
May 12, 2023 | PRESIDENT, REGENERATIVE MED. | -5.87K | $5.93 | -$34.78K | SELL | -1.74% | 331.77K | May 10 | ||
May 12, 2023 | CHIEF ACCOUNTING OFFICER | -1.59K | $5.93 | -$9.45K | SELL | -0.86% | 184.22K | May 10 | ||
May 12, 2023 | CHIEF FINANCIAL OFFICER | -5.98K | $5.93 | -$35.41K | SELL | -0.90% | 656.43K | May 10 | ||
May 09, 2023 | PRESIDENT, REGENERATIVE MED. | -51.76K | $5.34 | -$276.47K | SELL | -13.29% | 337.64K | May 04 | ||
May 03, 2023 | CHIEF ACCOUNTING OFFICER | -5.20K | $3.80 | -$19.74K | SELL | -2.72% | 185.81K | May 02 | ||
Apr 27, 2023 | CHIEF ACCOUNTING OFFICER | -1.63K | $3.74 | -$6.10K | SELL | -0.85% | 191.01K | Apr 25 | ||
Apr 27, 2023 | PRESIDENT, REGENERATIVE MED. | -5.99K | $3.74 | -$22.42K | SELL | -1.51% | 389.40K | Apr 25 | ||
Apr 27, 2023 | GENERAL COUNSEL AND CAO | -5.99K | $3.74 | -$22.42K | SELL | -1.28% | 462.43K | Apr 25 | ||
Apr 27, 2023 | CHIEF FINANCIAL OFFICER | -6.09K | $3.74 | -$22.82K | SELL | -0.91% | 662.41K | Apr 25 | ||
Apr 13, 2023 | CHIEF ACCOUNTING OFFICER | -1.63K | $3.31 | -$5.40K | SELL | -0.84% | 192.64K | Apr 11 | ||
Apr 13, 2023 | PRESIDENT, REGENERATIVE MED. | -6.00K | $3.31 | -$19.85K | SELL | -1.49% | 395.39K | Apr 11 | ||
Apr 13, 2023 | GENERAL COUNSEL AND CAO | -6.00K | $3.31 | -$19.84K | SELL | -1.26% | 468.42K | Apr 11 | ||
Apr 13, 2023 | CHIEF FINANCIAL OFFICER | -6.10K | $3.31 | -$20.19K | SELL | -0.90% | 668.50K | Apr 11 | ||
Mar 09, 2023 | PRESIDENT, REGENERATIVE MED. | -12.36K | $4.24 | -$52.44K | SELL | -4.43% | 266.32K | Mar 07 | ||
Mar 09, 2023 | CHIEF ACCOUNTING OFFICER | -3.40K | $4.24 | -$14.41K | SELL | -2.35% | 141.24K | Mar 07 | ||
Mar 09, 2023 | CHIEF FINANCIAL OFFICER | -12.06K | $4.24 | -$51.17K | SELL | -2.21% | 534.15K | Mar 07 | ||
Mar 09, 2023 | GENERAL COUNSEL AND CAO | -11.31K | $4.24 | -$48.00K | SELL | -3.24% | 338.05K | Mar 07 | ||
Feb 24, 2023 | CHIEF FINANCIAL OFFICER | -19.00K | $4.50 | -$85.42K | SELL | -3.36% | 546.21K | Feb 23 | ||
Feb 24, 2023 | GENERAL COUNSEL AND CAO | -15.55K | $4.53 | -$70.48K | SELL | -4.26% | 349.36K | Feb 23 | ||
Dec 27, 2022 | CHIEF FINANCIAL OFFICER | -4.99K | $2.82 | -$14.05K | SELL | -0.88% | 565.21K | Dec 22 | ||
Sep 14, 2022 | PRESIDENT, REGENERATIVE MED. | -27.33K | $3.44 | -$94.07K | SELL | -8.93% | 278.67K | Sep 12 - Sep 13 | ||
Aug 16, 2022 | PRESIDENT, REGENERATIVE MED. | -8.50K | $4.04 | -$34.34K | SELL | -2.70% | 306.00K | Aug 12 | ||
Aug 11, 2022 | PRESIDENT, WC & SURGICAL | -12.34K | $4.21 | -$51.94K | SELL | -2.79% | 430.07K | Aug 09 | ||
Aug 08, 2022 | PRESIDENT, REGENERATIVE MED. | -19.50K | $3.62 | -$70.59K | SELL | -5.84% | 314.50K | Aug 04 | ||
Jun 30, 2022 | PRESIDENT, REGENERATIVE MED. | -14.60K | $3.47 | -$50.66K | SELL | -4.19% | 334.00K | Jun 28 | ||
Jun 13, 2022 | CHIEF EXECUTIVE OFFICER | -112.00K | $3.75 | -$420.00K | SELL | -6.14% | 1.71M | Jun 09 | ||
May 10, 2022 | CHIEF ACCOUNTING OFFICER | -5.75K | $3.81 | -$21.91K | SELL | -3.82% | 144.64K | May 06 | ||
May 10, 2022 | SVP & CHIEF COMPLIANCE OFFICER | -3.89K | $3.50 | -$13.62K | SELL | -2.83% | 133.61K | May 09 | ||
May 04, 2022 | SVP, OPERATIONS & PROCUREMENT | -5.26K | $4.00 | -$21.05K | SELL | -2.27% | 226.64K | May 02 | ||
Mar 10, 2022 | CHIEF EXECUTIVE OFFICER | -45.61K | $4.86 | -$221.62K | SELL | -3.60% | 1.22M | Mar 08 | ||
Mar 10, 2022 | SVP, OPERATIONS & PROCUREMENT | -4.16K | $4.86 | -$20.19K | SELL | -2.38% | 170.43K | Mar 08 | ||
Mar 10, 2022 | EVP & CHIEF COMMERCIAL OFFICER | -8.77K | $4.86 | -$42.61K | SELL | -3.22% | 263.84K | Mar 08 | ||
Mar 10, 2022 | SVP & CHIEF COMPLIANCE OFFICER | -3.23K | $4.86 | -$15.71K | SELL | -3.51% | 89.01K | Mar 08 | ||
Mar 10, 2022 | CHIEF FINANCIAL OFFICER | -10.74K | $4.86 | -$52.20K | SELL | -2.73% | 382.70K | Mar 08 | ||
Mar 10, 2022 | GENERAL COUNSEL | -9.99K | $4.86 | -$48.54K | SELL | -5.09% | 186.34K | Mar 08 | ||
Mar 10, 2022 | EVP, RESEARCH AND DEVELOPMENT | -11.67K | $4.86 | -$56.71K | SELL | -6.42% | 170.03K | Mar 08 | ||
Mar 10, 2022 | CHIEF ACCOUNTING OFFICER | -3.27K | $4.86 | -$15.88K | SELL | -3.25% | 97.36K | Mar 08 | ||
Mar 01, 2022 | CHIEF FINANCIAL OFFICER | -17.40K | $4.83 | -$84.08K | SELL | -4.24% | 393.44K | Feb 25 | ||
Feb 28, 2022 | SVP & CHIEF COMPLIANCE OFFICER | -4.53K | $4.32 | -$19.54K | SELL | -4.68% | 92.25K | Feb 24 | ||
Feb 25, 2022 | CHIEF EXECUTIVE OFFICER | -61.00K | $4.31 | -$263.07K | SELL | -4.60% | 1.27M | Feb 23 | ||
Feb 25, 2022 | SVP, OPERATIONS & PROCUREMENT | -5.74K | $4.50 | -$25.82K | SELL | -3.18% | 174.59K | Feb 23 | ||
Feb 25, 2022 | GENERAL COUNSEL | -13.50K | $4.41 | -$59.53K | SELL | -6.43% | 196.34K | Feb 23 | ||
Aug 17, 2021 | EVP, RESEARCH AND DEVELOPMENT | -9.36K | $11.85 | -$110.97K | SELL | -4.90% | 181.71K | Aug 16 | ||
Jun 09, 2021 | CHIEF EXECUTIVE OFFICER | -101.96K | $0.00 | $0.00 | SELL | -7.13% | 1.33M | Jun 08 |
Explora operaciones con información privilegiada sobre todos los valores.